Neuroethics
News and analysis on the implications of brain science
The Neuroethics Blog | September 12, 2017
In this era in which science is ignored, deemed irrelevant, or actively suppressed, there is "a growing need for people in all the sciences and in ethics to speak out and to educate, wherever possible."
|
by Alexander Lees
BBC.com | September 9, 2017
Do we all have the right to enhance our bodies as technology and pharmaceuticals (and caffeine) will allow, or is that immoral? As the probably over-used term has it, would that be "playing God"? And who gets to decide?
|
by John Pavlus
Quartz | September 6, 2017
Using the same science-fictional shorthand to describe anything from self-driving cars to slightly better ad targeting surely inhibits basic comprehension. But its potential for seeding both magical thinking and abject confusion about real economic, social, and political changes also seems bottomless. If the experts don’t really know what they talk about when they talk about AI, is it any wonder that you and I don’t, either?
|
by Joseph J. Fins
New York Times Opinion Pages | August 24, 2017
If we reconceived rehabilitation as education, no one would graduate after a six-week course of care. Instead, we would promote lifelong learning as a means to achieve a recovered life. If there is a legal obligation to educate the developing brain, should there not be a correlative responsibility to those whose brain are in a process of redevelopment and recovery?
See also
|
by Bruno Martin
Nature | August 23, 2017
Metal antennas that send and receive TV signals and radio waves could soon be replaced by tiny films up to one hundred times smaller, scientists say. Among the possible benefits are smaller smartphones and wearable technology, and miniaturized implantable devices to stimulate brain cells.
|
 |
by The International Neuroethics Society
Dana blog | August 22, 2017
In advance of the International Neuroethics Society's annual meeting, an interview with Karola Kreitmair, philosopher, researcher, and playwright, who will be giving the "rising star" plenary lecture.
|
by Jeff Lyon
JAMA | August 16, 2017
A placebo-controlled study suggesting that cognition-enhancing drugs (CEs) can improve a chess player’s performance and a related survey indicating that nearly 10% of ranked German chess players have taken them during competition have thrown the spotlight once again on “smart pills,” their purported benefits, and uncharted dangers.
|
by Heather Murphy
New York Times | August 16, 2017
Matching up photos of strangers’ faces is surprisingly difficult, and the average person is likely to be duped by matching hairstyles.
|
by Philip Gerrans
Aeon | August 8, 2017
Psychedelics have a remarkable capacity to violate our ideas about ourselves. Is that why they make people better?
|
by Gail Heyman
The Conversation | August 3, 2017
One way research psychologists have sought to understand the reasoning behind the choice to lie versus tell the truth is to go back to when we first learn this skill in childhood.
|
by Stephen J. Morse
The Neuroethics Blog | August 1, 2017
Despite the astonishing advances in neuroscience, most of what we know is not legally relevant, has not transformed doctrine, and has had scant influence on practice except in death penalty proceedings.
|
by Julie Zauzmer
Washington Post | July 24, 2017
In the Hopkins and NYU study, two dozen clergy — including priests, pastors and rabbis — are taking controlled doses of psilocybin, the drug found in psychedelic mushrooms, under the watchful eye of scientists.
|
Page: 1 of 9
